Page 201 - Read Online
P. 201

Topic: Neurovascular and neuroinflammation mechanisms

             associated with bipolar disorder



           Neurovascular and neuroinflammatory

           mechanisms associated with mood disorders



           Gianfranco Spalletta , Gabriele Sani 3,4
                             1,2
           1 Neuropsychiatry Laboratory, Department of Clinical and Behavioral Neurology, Scientific Institute for Research, Hospitalisation
           and Health Care, Santa Lucia Foundation, 00179 Rome, Italy.
           2 Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX 77030, USA.
           3 Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome, School of Medicine and
           Psychology, Sant’Andrea Hospital, 00192 Rome, Italy.
           4 Centro Lucio Bini, 00193 Rome, Italy.


           According to the World Health Organization, mood   IL‑18, tumor necrosis factor‑α (TNF‑α), interferon‑α and
           disorders are a major source of morbidity, disability   brain‑derived neurotrophic factor]. [5‑8]
           and mortality worldwide.  In fact, they are the
                                    [1]
                                 [2]
           leading cause of suicide.  Consistent data have been   The advent of the psychopharmacological era, in
           collected regarding their epidemiology and clinical,   general,  and  of  antidepressants,  in  particular,  led
           neurobiological and neuropsychological characteristics   clinicians and researchers to concentrate their efforts on
           but their etiology and pathophysiology still remain to   the monoaminergic hypothesis of mood disorders. This
           be elucidated. The dearth of data limits the possibility   research line became the standard against which every
           of developing new therapeutic strategies aimed at   case had to be measured. In fact, bioamine research in
           improving patient outcomes.                        mood disorders attracted the vast majority of resources.
                                                              Although this research line helped the scientific
           Recently, an increasing number of studies have focused on   community gain some insights into the pathophysiology
           neuroinflammation as a potential mechanism involved   of mood disorders, it did not succeed in dissecting
           in the etiopathogenesis of mood disorders.  Before   the mystery of mood disorder mechanisms. Some
                                                   [3]
           this, a possible relationship between inflammation and   anti‑inflammatory properties of anti‑depressants  and
                                                                                                         [9]
           psychiatric disorders had been hypothesized. Julius   mood stabilizers  such as serotonin selective reuptake
                                                                             [10]
           Wagner‑Jauregg, the first psychiatrist to be awarded the   inhibitors, lithium and valproate have been found, but
           Nobel Prize in 1927, started from the observations of   studies are still few and results are inconsistent. Thus,
           Hippocrates and Galen and noted that patients diagnosed   there is a need to explore new pathways to improve our
           with psychiatric disorders improved after fever attacks.   understanding and develop new treatments.
           Thus, he proposed treating them by artificially inducing
           fever (pyretotherapy).  This treatment strategy implies a   Inflammation is a fundamental physiological
                             [4]
           primary role of inflammation in the pathophysiology of   homeostatic response of the entire body, which is
           psychiatric disorders. More recently, this view received   connected to the stress response, making it part of
           new impetus from studies that focused on several   Selye’s “general adaptation syndrome”. [11]  It may
           inflammatory biomarkers [e.g. interleukin‑1 (IL‑1), IL‑6,   produce beneficial effects if it is working well and is
                                                              well‑tuned, or it may produce damage and unintended
                                                              consequences if there is something wrong with its
           Corresponding Author: Dr. Gianfranco Spalletta,
           Neuropsychiatry Laboratory, Department of Clinical and   mechanisms, causing it to function inadequately.
           Behavioral Neurology, Scientific Institute for Research,   Undesired consequences may include alterations of
           Hospitalisation and Health Care Santa Lucia Foundation,    mood, sleep, food intake, energy, volition and cognition,
           Via Ardeatina 306, 00179 Rome, Italy.
           E‑mail: g.spalletta@hsantalucia.it
                                                              This is an open access article distributed under the terms of the Creative
                                                              Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows
                          Access this article online          others to remix, tweak, and build upon the work non-commercially, as long as the
                                                              author is credited and the new creations are licensed under the identical terms.
               Quick Response Code:
                                    Website:                  For reprints contact: nn_editor001@nnjournal.net
                                    www.nnjournal.net
                                                               Cite this article as:  Spalletta G, Sani G. Neurovascular and
                                    DOI:                       neuroinflammatory mechanisms associated with mood disorders.
                                    10.4103/2347-8659.167306   Neuroimmunol Neuroinflammation 2015;2:193-4.
                                                               Received: 11-04-2015; Accepted: 20-04-2015



          © 2015 Neuroimmunology and Neuroinflammation | Published by Hongkong Partner Publishing Co. Limited   193
   196   197   198   199   200   201   202   203   204   205   206